🇺🇸 FDA
Patent

US 7183065

Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens

granted A61KA61K38/1709A61P

Quick answer

US patent 7183065 (Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens) held by The Regents of the University of California expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/1709, A61P, A61P1/04, A61P37/02